Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 6/2018

01-11-2018 | Clinical Investigation

Posterior subtenon infusion of triamcinolone acetonide as adjunctive treatment to panretinal photocoagulation using pattern scan laser for diabetic retinopathy

Authors: Yutaka Yamada, Yoshihiro Takamura, Takehiro Matsumura, Masakazu Morioka, Makoto Gozawa, Masaru Inatani

Published in: Japanese Journal of Ophthalmology | Issue 6/2018

Login to get access

Abstract

Purpose

To estimate the effect of sub-Tenon’s capsule triamcinolone acetonide injection (STTA) combined with panretinal photocoagulation (PRP) using pattern scan laser (PSL) for high risk non-proliferative diabetic retinopathy (NPDR), in terms of the inflammation and the progression of diabetic macular edema (DME).

Study design

Retrospective comparative analysis.

Methods

NPDR patients who underwent PRP using PSL with (STTA+PSL group, n=24) or without (PSL group, n=19) pretreatment of STTA were enrolled. We measured anterior flare intensity (AFI) and central retinal thickness (CRT) at day of STTA (day 0), and at 1, 3, 7, 11 and 15 weeks.

Results

The CRT of the STTA+PSL group was significantly lower than that of the PSL group at 7 (308.15±69.16 μm versus 340.21±77.91 μm, p = 0.04), 11 (283.8±60.75 μm versus 335.7±67.70 μm, p = 0.01) and 15 weeks (281.13±35.29 μm versus 316.58±54.89 μm, p = 0.02). AFI levels in the STTA+PSL group were significantly lower than those in the PSL group at 11 (10.47±3.40 versus 15.85±8.38, p = 0.007) and 15 weeks (11.38±3.31 versus 14.37±3.85, p = 0.009). The significant improvement in CRT from baseline was noticed through the observational periods in STTA+PSL group, but not in the PSL group.

Conclusion

Pretreatment of STTA has the potential to not only prevent the worsening of DME, but also reduce the CRT and AFI of eyes with NPDR after PRP using PSL.
Literature
1.
go back to reference Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88:583–600. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88:583–600.
2.
go back to reference Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol. 1986;104:34–41. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol. 1986;104:34–41.
3.
go back to reference Vander JF, Duker JS, Benson WE, Brown GC, McNamara JA, Rosenstein RB. Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology. 1991;98:1575–9.CrossRef Vander JF, Duker JS, Benson WE, Brown GC, McNamara JA, Rosenstein RB. Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology. 1991;98:1575–9.CrossRef
4.
go back to reference Chew EY, Ferris FL 3rd, Csaky KG, Murphy RP, Agrón E, Thompson DJ, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: The early treatment diabetic retinopathy follow-up study. Ophthalmology. 2003;110:1683–9.CrossRef Chew EY, Ferris FL 3rd, Csaky KG, Murphy RP, Agrón E, Thompson DJ, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: The early treatment diabetic retinopathy follow-up study. Ophthalmology. 2003;110:1683–9.CrossRef
5.
go back to reference Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98:766–85. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98:766–85.
6.
go back to reference Arimura S, Takamura Y, Miyake S, Gozawa M, Iwasaki K, Tomomatsu T, et al. The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits. Exp Eye Res. 2016;149:1–7.CrossRef Arimura S, Takamura Y, Miyake S, Gozawa M, Iwasaki K, Tomomatsu T, et al. The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits. Exp Eye Res. 2016;149:1–7.CrossRef
7.
go back to reference Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247:1617–24.CrossRef Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247:1617–24.CrossRef
8.
go back to reference Shimura M, Yasuda K, Shiono T. Posterior sub-Tenon’s capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Ophthalmology. 2006;113:381–7.CrossRef Shimura M, Yasuda K, Shiono T. Posterior sub-Tenon’s capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Ophthalmology. 2006;113:381–7.CrossRef
9.
go back to reference Costa JF, Sousa K, Marques JP, Marques M, Cachulo ML, Silva R, et al. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema. Eur J Ophthalmol. 2016;26:485–90.CrossRef Costa JF, Sousa K, Marques JP, Marques M, Cachulo ML, Silva R, et al. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema. Eur J Ophthalmol. 2016;26:485–90.CrossRef
10.
go back to reference Ercalik NY, Yenerel NM, Imamoglu S, Kumral ET, Vural ET. Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment. J Ocul Pharmacol Ther. 2016;32:225–9.CrossRef Ercalik NY, Yenerel NM, Imamoglu S, Kumral ET, Vural ET. Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment. J Ocul Pharmacol Ther. 2016;32:225–9.CrossRef
11.
go back to reference Ozkurt YB, Akkaya S, Aksoy S, Evciman T, Haboğlu M. Posterior subtenon’s capsule triamcinolone acetonide injection for the treatment of diabetic macular edema. J Ocul Pharmacol Ther. 2015;31:455–60.CrossRef Ozkurt YB, Akkaya S, Aksoy S, Evciman T, Haboğlu M. Posterior subtenon’s capsule triamcinolone acetonide injection for the treatment of diabetic macular edema. J Ocul Pharmacol Ther. 2015;31:455–60.CrossRef
12.
go back to reference Oshitari T, Kitamura Y, Nonomura S, Arai M, Takatsuna Y, Sato E, et al. Risk factors for refractory diabetic macular oedema after sub-tenon’s capsule triamcinolone acetonide injection. J Ophthalmol. 2015;2015:195737.PubMedPubMedCentral Oshitari T, Kitamura Y, Nonomura S, Arai M, Takatsuna Y, Sato E, et al. Risk factors for refractory diabetic macular oedema after sub-tenon’s capsule triamcinolone acetonide injection. J Ophthalmol. 2015;2015:195737.PubMedPubMedCentral
13.
go back to reference Gillies MC, Islam FM, Larsson J, Pasadhika S, Gaston C, Zhu M, et al. Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. Clin Exp Ophthalmol. 2010;38:605–12.CrossRef Gillies MC, Islam FM, Larsson J, Pasadhika S, Gaston C, Zhu M, et al. Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. Clin Exp Ophthalmol. 2010;38:605–12.CrossRef
14.
go back to reference Muqit MMK, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye. 2011;25:1447–56.CrossRef Muqit MMK, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye. 2011;25:1447–56.CrossRef
15.
go back to reference Ito A, Hirano Y, Nozaki M, Ashikari M, Sugitani K, Ogura Y. Short pulse laser induces less inflammatory cytokines in the murine retina after laser photocoaguration. Ophothalmic Res. 2015;53:65–73.CrossRef Ito A, Hirano Y, Nozaki M, Ashikari M, Sugitani K, Ogura Y. Short pulse laser induces less inflammatory cytokines in the murine retina after laser photocoaguration. Ophothalmic Res. 2015;53:65–73.CrossRef
16.
go back to reference Takamura Y, Arimura S, Miyake S, Matsumura T, Gozawa M, Iwasaki K, et al. Panretinal photocoagulation using short-pulse laser induces lessinflammation and macular thickening in patients with diabetic retinopathy. J Ophthalmol. 2017;2017:8530261.PubMedPubMedCentral Takamura Y, Arimura S, Miyake S, Matsumura T, Gozawa M, Iwasaki K, et al. Panretinal photocoagulation using short-pulse laser induces lessinflammation and macular thickening in patients with diabetic retinopathy. J Ophthalmol. 2017;2017:8530261.PubMedPubMedCentral
17.
go back to reference Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445–50.CrossRef Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445–50.CrossRef
18.
go back to reference Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2006;113:294–301.CrossRef Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2006;113:294–301.CrossRef
19.
go back to reference Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46:1440–4.CrossRef Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46:1440–4.CrossRef
20.
go back to reference Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem Mol. Biol. 2006;39:469–78.PubMed Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem Mol. Biol. 2006;39:469–78.PubMed
21.
go back to reference Noma H, Mimura T, Yasuda K, Shimura M. Cytokine kinetics after monthly intravitreal bevacizumab for retinal vein occlusion associated with macular oedema. Ophthalmic Res. 2016;56:207–14.CrossRef Noma H, Mimura T, Yasuda K, Shimura M. Cytokine kinetics after monthly intravitreal bevacizumab for retinal vein occlusion associated with macular oedema. Ophthalmic Res. 2016;56:207–14.CrossRef
22.
go back to reference Noma H, Mimura T, Shimura M. Role of inflammation in diabetic macular edema. Ophthalmologica. 2014;232:127–35.CrossRef Noma H, Mimura T, Shimura M. Role of inflammation in diabetic macular edema. Ophthalmologica. 2014;232:127–35.CrossRef
23.
go back to reference Shimura M, Yasuda K, Nakazawa T, Shiono T, Sakamoto T, Nishida K. Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol. 2009;247:907–12.CrossRef Shimura M, Yasuda K, Nakazawa T, Shiono T, Sakamoto T, Nishida K. Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol. 2009;247:907–12.CrossRef
Metadata
Title
Posterior subtenon infusion of triamcinolone acetonide as adjunctive treatment to panretinal photocoagulation using pattern scan laser for diabetic retinopathy
Authors
Yutaka Yamada
Yoshihiro Takamura
Takehiro Matsumura
Masakazu Morioka
Makoto Gozawa
Masaru Inatani
Publication date
01-11-2018
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 6/2018
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-018-0628-z

Other articles of this Issue 6/2018

Japanese Journal of Ophthalmology 6/2018 Go to the issue

Scientific Reviewers

Scientific Reviewers